Uridine decreases morphine-induced behavioral sensitization by decreasing dorsal striatal dopamine release possibly via agonistic effects at GABAA receptors

European Neuropsychopharmacology

Volumn 24, Issue 9, 2014, Pages 1557-1566

  Liu, Ping ^a   Wu, Chunfu ^a   Song, Wu ^a   Yu, Lisha ^a   Yang, Xiaofeng ^a   Xiang, Rongwu ^a   Wang, Fang ^a   Yang, Jingyu ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Dopamine; Dorsal striatum; Microdialysis; Morphine; Uridine; alanine

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; BETA ALANINE; BICUCULLINE; DOPAMINE; MORPHINE; SURAMIN; URACIL; URIDINE; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; NARCOTIC ANALGESIC AGENT;

AGONIST; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BEHAVIOR DISORDER; BEHAVIORAL SENSITIZATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; HYPERACTIVITY; LATERAL BRAIN VENTRICLE; LOCOMOTION; MALE; MICRODIALYSIS; MOUSE; NEUROMODULATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SENSITIZATION; ANIMAL; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; INBRED STRAIN; METABOLISM; MOTOR ACTIVITY; TIME;

ANALGESICS, OPIOID; ANIMALS; ANIMALS, INBRED STRAINS; BETA-ALANINE; BICUCULLINE; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; GABA-A RECEPTOR AGONISTS; GABA-A RECEPTOR ANTAGONISTS; MALE; MICE; MORPHINE; MOTOR ACTIVITY; RECEPTORS, GABA-A; TIME FACTORS; URACIL; URIDINE;

EID: 84907598848     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2014.06.010     Document Type: Article

References (37)

1. Agnati L.F., Fuxe K., Ruggeri M., Merlo Pich E., Benfenati F., Volterra V., Ungerstedt U., Zini I. Effects of chronic treatment with uridine on striatal dopamine release and dopamine related behaviours in the absence or the presence of chronic treatment with haloperidol. Neurochem. Int. 1989, 15:107-113.
2. Baudry A., Mouillet-Richard S., Schneider B., Launay J.M., Kellermann O. miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants. Science 2010, 329:1537-1541.
3. Borycz J., Borycz J.A., Edwards T.N., Boulianne G.L., Meinertzhagen I.A. The metabolism of histamine in the Drosophila optic lobe involves an ommatidial pathway: beta-alanine recycles through the retina. J. Exp. Biol. 2012, 215:1399-1411.
4. Connolly G.P., Duley J.A. Uridine and its nucleotides: biological actions, therapeutic potentials. Trends Pharmacol. Sci. 1999, 20:218-225.
5. Cordonnier L., Sanchez M., Roques B.P., Noble F. Blockade of morphine-induced behavioral sensitization by a combination of amisulpride and RB101, comparison with classical opioid maintenance treatments. Br. J. Pharmacol. 2007, 151:94-102.
6. Dobolyi A., Juhasz G., Kovacs Z., Kardos J. Uridine function in the central nervous system. Curr. Top. Med. Chem. 2011, 11:1058-1067.
7. Farabegoli C., Merlo Pich E., Cimino M., Agnati L.F., Fuxe K. Chronic uridine treatment reduces the level of [3H]spiperone-labelled dopamine receptors and enhances their turnover rate in striatum of young rats: relationship to dopamine-dependent behaviours. Acta Physiol. Scand. 1988, 132:209-216.
8. Giuffrida A., Parsons L.H., Kerr T.M., Rodriguez de Fonseca F., Navarro M., Piomelli D. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat. Neurosci. 1999, 2:358-363.
9. Guarneri P., Guarneri R., La Bella V., Piccoli F. Interaction between uridine and GABA-mediated inhibitory transmission: studies in vivo and in vitro. Epilepsia 1985, 26:666-671.
10. Guarneri P., Guarneri R., Mocciaro C., Piccoli F. Interaction of uridine with GABA binding sites in cerebellar membranes of the rat. Neurochem. Res. 1983, 8:1537-1545.
11. Hao Y., Wu C.F., Yang J.Y. Lesions of the medial prefrontal cortex prevent the induction but not expression of morphine-induced behavioral sensitization in mice. Neurosci. Lett. 2007, 417:225-230.
12. Hao Y., Yang J.Y., Guo M., Wu C.F., Wu M.F. Morphine decreases extracellular levels of glutamate in the anterior cingulate cortex: an in vivo microdialysis study in freely moving rats. Brain. Res. 2005, 1040:191-196.
13. Hao Y., Yang J.Y., Wu C.F., Wu M.F. Pseudoginsenoside-F11 decreases morphine-induced behavioral sensitization and extracellular glutamate levels in the medial prefrontal cortex in mice. Pharmacol. Biochem. Behav. 2007, 86:660-666.
14. Ipata P.L., Barsotti C., Tozzi M.G., Camici M., Balestri F. Metabolic interplay between intra- and extra-cellular uridine metabolism via an ATP driven uridine-UTP cycle in brain. Int. J. Biochem. Cell Biol. 2010, 42:932-937.
15. Ito R., Dalley J.W., Robbins T.W., Everitt B.J. Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. J. Neurosci. 2002, 22:6247-6253.
16. Kalivas P.W., Pierce R.C., Cornish J., Sorg B.A. A role for sensitization in craving and relapse in cocaine addiction. J. Psychopharmacol. 1998, 12:49-53.
17. Kimura T., Ho I.K., Yamamoto I. Uridine receptor: discovery and its involvement in sleep mechanism. Sleep 2001, 24:251-260.
18. Kovacs Z., Dobolyi A., Juhasz G., Kekesi K.A. Nucleoside map of the human central nervous system. Neurochem. Res. 2010, 35:452-464.
19. Kulkarni A., McVaugh W., Lawrence B., Pizzini R., Wolinsky I., VanBuren C., Rudolph F., Dafny N. Nutritional supplementation of nucleotides restores opioid CNS-mediated phenomena in mice. Life Sci. 1997, 61:1691-1696.
20. Leite-Morris K.A., Fukudome E.Y., Kaplan G.B. Opiate-induced motor stimulation is regulated by γ-aminobutyric acid type B receptors found in the ventral tegmental area in mice. Neurosci. Lett. 2002, 317:119-122.
21. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 1995, 18:22-29.
22. Myers C.S., Fisher H., Wagner G.C. Uridine reduces rotation induced by L-dopa and methamphetamine in 6-OHDA-treated rats. Pharmacol. Biochem. Behav. 1995, 52:749-753.
23. Myers C.S., Napolitano M., Fisher H., Wagner G.C. Uridine and stimulant-induced motor activity. Proc. Soc. Exp. Biol. Med. 1993, 204:49-53.
24. Ojanen S., Koistinen M., Backstrom P., Kankaanpaa A., Tuomainen P., Hyytia P., Kiianmaa K. Differential behavioural sensitization to intermittent morphine treatment in alcohol-preferring AA and alcohol-avoiding ANA rats: role of mesolimbic dopamine. Eur. J. Neurosci. 2003, 17:1655-1663.
25. Paxinos G., Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates 2001, Academic Press, San Diego. 2nd ed.
26. Peters G.J., van Groeningen C.J., Laurensse E., Kraal I., Leyva A., Lankelma J., Pinedo H.M. Effect of pyrimidine nucleosides on body temperatures of man and rabbit in relation to pharmacokinetic data. Pharm. Res. 1987, 4:113-119.
27. Peters G.J., van Groeningen C.J., Laurensse E.J., Lankelma J., Leyva A., Pinedo H.M. Uridine-induced hypothermia in mice and rats in relation to plasma and tissue levels of uridine and its metabolites. Cancer Chemother. Pharmacol. 1987, 20:101-108.
28. Qi J., Han W.Y., Yang J.Y., Wang L.H., Dong Y.X., Wang F., Song M., Wu C.F. Oxytocin regulates changes of extracellular glutamate and GABA levels induced by methamphetamine in the mouse brain. Addict. Biol. 2012, 17:758-769.
29. Qi J., Yang J.Y., Song M., Li Y., Wang F., Wu C.F. Inhibition by oxytocin of methamphetamine-induced hyperactivity related to dopamine turnover in the mesolimbic region in mice. Naunyn Schmiedebergs Arch. Pharmacol. 2008, 376:441-448.
30. Shuto T., Kuroiwa M., Hamamura M., Yabuuchi K., Shimazoe T., Watanabe S., Nishi A., Yamamoto T. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist. Neuropharmacology 2006, 50:991-997.
31. Song W., Wu C.F., Liu P., Xiang R.W., Wang F., Dong Y.X., Yang J.Y. Characterization of basal and morphine-induced uridine release in the striatum: an in vivo microdialysis study in mice. Neurochem. Res. 2013, 38:153-161.
32. Sun J.Y., Yang J.Y., Wang F., Wang J.Y., Song W., Su G.Y., Dong Y.X., Wu C.F. Lesions of nucleus accumbens affect morphine-induced release of ascorbic acid and GABA but not of glutamate in rats. Addict. Biol. 2011, 16:540-550.
33. Tiedje K.E., Stevens K., Barnes S., Weaver D.F. Beta-alanine as a small molecule neurotransmitter. Neurochem. Int. 2010, 57:177-188.
34. Wang T.L., Wu C.F., Yang J.Y., Wang F., Song W. Effect of morphine on brain uracil release in mouse striatum detected by microdialysis. Neurosci. Lett. 2009, 457:89-92.
35. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 1998, 54:679-720.
36. Wu C.F., Bertorelli R., Sacconi M., Pepeu G., Consolo S. Decrease of brain acetylcholine release in aging freely-moving rats detected by microdialysis. Neurobiol. Aging 1988, 9:357-361.
37. Yamamoto T., Koyama H., Kurajoh M., Shoji T., Tsutsumi Z., Moriwaki Y. Biochemistry of uridine in plasma. Clin. Chim. Acta 2011, 412:1712-1724.